ICN Pharmaceuticals Inc.: Shares of ICN and...
- Share via
ICN Pharmaceuticals Inc.: Shares of ICN and two of its subsidiaries rose sharply Monday after the company said it expected to announce “big news” today.
The Costa Mesa pharmaceutical company’s stock closed at $10.50, up $1.375, on heavy trading on the New York Stock Exchange. Two other firms in which ICN Pharmaceuticals owns substantial stakes also surged.
Shares of SPI Pharmaceuticals Inc. shot up $2.125 to close at $21 per share. Meanwhile, Viratek Inc. was up $1 to finish at $10.75. A third subsidiary, ICN Biomedicals Inc., closed at $3.50, up 18.75 cents.
ICN Pharmaceuticals did not elaborate on its expected announcement, and officials were not immediately available for comment about Monday’s stock gains.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
